Found: 16
Select item for more details and to access through your institution.
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1304, doi. 10.1002/pros.23838
- By:
- Publication type:
- Article
Circulating inflammation markers and prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1338, doi. 10.1002/pros.23842
- By:
- Publication type:
- Article
Inflammation‐associated pathologies in a case of prostate schistosomiasis: Implications for a causal role in prostate carcinogenesis.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1316, doi. 10.1002/pros.23841
- By:
- Publication type:
- Article
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1347, doi. 10.1002/pros.23843
- By:
- Publication type:
- Article
CUL4B regulates cancer stem‐like traits of prostate cancer cells by targeting BMI1 via miR200b/c.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1294, doi. 10.1002/pros.23835
- By:
- Publication type:
- Article
Establishing a cryopreservation protocol for patient‐derived xenografts of prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1326, doi. 10.1002/pros.23839
- By:
- Publication type:
- Article
Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1284, doi. 10.1002/pros.23834
- By:
- Publication type:
- Article
Comparative analysis of p16 expression among African American and European American prostate cancer patients.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1274, doi. 10.1002/pros.23833
- By:
- Publication type:
- Article
PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1267, doi. 10.1002/pros.23831
- By:
- Publication type:
- Article
Distinct expression patterns of SULT2B1b in human prostate epithelium.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1256, doi. 10.1002/pros.23829
- By:
- Publication type:
- Article
Heat injured stromal cells‐derived exosomal EGFR enhances prostatic wound healing after thulium laser resection through EMT and NF‐κB signaling.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1238, doi. 10.1002/pros.23827
- By:
- Publication type:
- Article
E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1226, doi. 10.1002/pros.23806
- By:
- Publication type:
- Article
Outcome of Botulinum Toxin‐A intraprostatic injection for benign prostatic hyperplasia induced lower urinary tract symptoms: A prospective multicenter study.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1221, doi. 10.1002/pros.23805
- By:
- Publication type:
- Article
Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1211, doi. 10.1002/pros.23804
- By:
- Publication type:
- Article
hnRNPM, a potential mediator of YY1 in promoting the epithelial‐mesenchymal transition of prostate cancer cells.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1199, doi. 10.1002/pros.23790
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1197, doi. 10.1002/pros.23678
- Publication type:
- Article